OR WAIT null SECS
November 02, 2022
Gerresheimer and Nelson Labs will work together to conduct extractables and leachables testing on upcoming primary packaging solutions.
Under this deal, Merck, known as MSD outside of the United States and Canada, will select Veeva products for industry-specific software and data.
Johnson & Johnson’s acquisition of Abiomed, a provider of heart pump technologies, is designed to bolster their position in the medical technology sector.
New medications show exciting outcomes for weight loss.
Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates.
November 01, 2022
Purolite and Repligen have extended their existing ligand partnership through 2032.
October 25, 2022
Under two new agreements, Societal CDMO will offer analytical, technical transfer, formulation, manufacturing, and packaging services for novel therapeutics.
Under the new collaboration with Tempus, GSK will have access to de-identified patient data to accelerate drug discovery, improve clinical trial design, and speed up enrollment.
October 19, 2022
Gilead and MacroGenics will work together on bispecific antibodies for the treatment of blood cancers.
October 14, 2022
Merck has exercised a $250 million option with Moderna to jointly develop and commercialize cancer vaccine mRNA-4157/V940.